Journal
PLOS PATHOGENS
Volume 18, Issue 8, Pages -Publisher
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.ppat.1010657
Keywords
-
Categories
Funding
- Collins Medical Trust (Portland, Oregon)
- Medical Research Foundation (Oregon Health & Sciences University, Portland, Oregon)
Ask authors/readers for more resources
Activation of the complement pathway leads to the production of bioactive C3a, which interacts with C3aR to regulate immune cell function and bacterial infection. Recent studies have shown that various cell types can produce intracellular C3a, suggesting a need to reassess the role of C3aR in controlling bacterial infections.
Activation of the complement pathway results in the production of bioactive C3a, a product of C3 cleavage, which interacts with membrane-bound receptor C3aR to regulate innate immune cell function and outcome of bacterial infection. Specifically, previous research has identified mechanistically distinct and cell type-specific roles for C3aR in regulating innate immune cell inflammatory state, antimicrobial killing capacity, and metabolism. Historically, the production of C3a has been relegated to the serum; however, recent studies have provided evidence that various cell types can produce intracellular C3a that stimulates intracellular C3aR. In light of these new results, it is imperative that we revisit previous studies regarding the role of C3aR in controlling bacterial infections and analyze these results in the context of both extracellular and intracellular C3a production and C3aR activation. Thus, this review will cover specific roles of C3aR in driving cell type-specific and tissue specific responses during bacterial infections and emphasize the contribution of the C3a-C3aR axis in regulating host resistance to bacterial infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available